$0.03
$0.00 (0.00%)
End-of-day quote: 05/08/2024
NasdaqCM:DMK
DMK Pharmaceuticals Annual Report
| Year | Year | 2018 | 2017 | 2016 | 2015 | 2014 | ||
|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$15.09M | $13.07M | $6.47M | $0.00M | $0.00M | |
| GM % | Gross Margin % |
|
35.06% | 43.24% | 25.03% | 0.00% | 0.00% | |
| OM | Operating Margin |
|
-261.51% | -188.88% | 0.00% | 0.00% | 0.00% | |
| EPS | Earnings Per Share |
|
$0.00 | $-70.16 | $-60.49 | $-83.30 | $-71.40 | $-77.70 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | |
| Sha. | Shares |
|
47.29m | 33.39m | 21.99m | 13.43m | 10.65m | |
| OCF | Operating Cash Flow |
|
$-32.66M | $-15.13M | $-21.16M | $-10.34M | $-8.75M | |
| FCF | Free Cash Flow |
|
$-36.19M | $-17.20M | $-21.28M | $-10.34M | $-6.88M | |
| FCFS | Free Cash Flow Per Share |
|
$-0.93 | $-0.61 | $-1.22 | $-0.78 | $-0.83 |
